PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

Go back to PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
(NASDAQ: PRFX) Delayed: 0.95 -0.02 (2.06%)
Previous Close $0.97    52 Week High
Open $0.99    52 Week Low
Day High $0.99    P/E N/A 
Day Low $0.93    EPS
Volume 26,250